Literature DB >> 10227811

Gammadelta receptor bearing T cells in scleroderma: enhanced interaction with vascular endothelial cells in vitro.

M B Kahaleh1, P S Fan, T Otsuka.   

Abstract

In view of the documented perivascular mononuclear cell infiltration in the involved organs in scleroderma (SSc) and the reported accumulation of gammadelta-T cells in SSc skin and lung, we evaluated gammadelta-T cell interaction with endothelial cells (EC) in vitro. gammadelta- and alphabeta-T cells were isolated from BPMN of SSc patients with early diffuse disease and of matched control subjects by an immunomagnetic method after stimulation with mycobacterium lysate and interleukin-2 for 2 weeks. Lymphocyte adhesion, proliferation, and cytotoxicity to EC were investigated. SSc gammadelta-T cells adhered to cultured EC and proliferated at higher rates than control cells. Furthermore, significant EC cytotoxicity by SSc gammadelta was seen. The cytotoxicity was blocked by addition of anti-gammadelta-TCR antibody and by anti-granzyme A antibody but not by anti-MHC class I and II antibodies. Expression of granzyme A mRNA was seen in five/five SSc gammadelta-T cells and in one/five control cells. alphabeta-T cells from both SSc and control subjects were significantly less interactive with EC than gammadelta-T cells. The data demonstrate EC recognition by SSc gammadelta-T cells and propose gammadelta-T cells as a possible effector cell type in the immune pathogenesis of SSc. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227811     DOI: 10.1006/clim.1999.4694

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization.

Authors:  R Giacomelli; P Cipriani; A Fulminis; G Barattelli; M Matucci-Cerinic; S D'Alò; G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 3.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

4.  MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts.

Authors:  D Hamamdzic; R A Harley; D Hazen-Martin; E C LeRoy
Journal:  BMC Musculoskelet Disord       Date:  2001-07-31       Impact factor: 2.362

5.  A Novel Prothrombotic Pathway in Systemic Sclerosis Patients: Possible Role of Bisphosphonate-Activated γδ T Cells.

Authors:  Victoria Marcu-Malina; Alexandra Balbir-Gurman; Rima Dardik; Yolanda Braun-Moscovici; Michael J Segel; Ilan Bank
Journal:  Front Immunol       Date:  2014-09-08       Impact factor: 7.561

6.  Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.

Authors:  Adi Mor; Michal Segal Salto; Avi Katav; Neta Barashi; Victoria Edelshtein; Mirko Manetti; Yair Levi; Jacob George; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2019-05-25       Impact factor: 19.103

Review 7.  Esophageal manifestation in patients with scleroderma.

Authors:  Theodoros A Voulgaris; Georgios P Karamanolis
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 8.  Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

Authors:  Cosimo Bruni; Tracy Frech; Mirko Manetti; Francesca Wanda Rossi; Daniel E Furst; Amato De Paulis; Felice Rivellese; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

Review 9.  The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases.

Authors:  Ilan Bank
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.